This trial is active, not recruiting.

Condition chronic obstructive pulmonary disease
Treatment spirometry
Phase phase 0
Sponsor Col·legi de Farmacèutics de la Província de Barcelona
Collaborator Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Start date October 2010
End date July 2012
Trial size 3600 participants
Trial identifier NCT01576068, 2008/3128/I


Chronic Obstructive Pulmonary Disease (COPD) is a prevalent disease. In the investigators country, underdiagnosis has been estimated in around 80% of subjects. Early detection is done mainly in primary care but due to actual situation new alternatives have been proposed to decrease underdiagnosis.

This present study promote by a multidisciplinary research team (respiratory medicine, primary care, nurse and pharmacist) raise the objective of evaluate the effect of a COPD case finding program guide by spirometry in community-pharmacies.

From the results of a pilot-study conducted in 13 community-pharmacies in Barcelona, in which the investigators showed the feasibility of spirometry in community-pharmacies for the early detection of COPD, the investigators have design a second phase to evaluate the effect of this strategy. 100 Barcelona's community-pharmacies during 6 months will select high risk customers and will conduct a spirometry in agreement with the design protocol. 3600 spirometries is the establish objective. Participants hospitals will train pharmacist in spirometry and also control spirometry quality daily by a telematic pathway. Spirometry results will be evaluate in terms of effect and costs. The investigators will also evaluate the impact of this program in the health system by numbers of subjects diagnosed and follow up in primary care.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose screening
Pharmacy customers with GOLD COPD Criteria of high-risk subjects.
Spirometry done in high-risk customers of community-pharmacies to detect airflow limitation

Primary Outcomes

COPD Case Finding
time frame: During 15 months pharmacies will include subjects with possible COPD through spirometry.

Eligibility Criteria

Male or female participants at least 40 years old.

Inclusion Criteria: - Age over 40 years. - Current or former smoker - Chronic respiratory symptoms(cough, shortness of breath, expectoration) Exclusion Criteria: - Previous diagnosed chronic lung disease - Use of inhalers

Additional Information

Official title Efficiency of COPD Case Finding Program by Spirometry in High-risk Customers of Urban Community Pharmacies
Principal investigator Diego Castillo, MD
Trial information was received from ClinicalTrials.gov and was last updated in April 2012.
Information provided to ClinicalTrials.gov by Col·legi de Farmacèutics de la Província de Barcelona.